与HPV表位体的TCR CDR3化学互补性与宫癌的更好的结果有关

Deo Rei L Agnila1, Rahul Jain1, Michael J Diaz1

  • 1Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, 33612, USA.

概括

人类乳头瘤病毒 (HPV) T细胞受体对特定HPV表位体的互补性与宫癌患者的生存率改善有关. 这些发现表明HPV免疫治疗的潜在新点.